Second potential coronavirus COVID-19 vaccine in US starts safety test
Inovio Pharmaceuticals said on Monday that the US Food and Drug Administration (FDA) has accepted the company`s Investigational New Drug (IND) application for INO-4800, its DNA vaccine candidate designed to prevent COVID-19 infection.